The biology and clinical impact of genetic lesions in myeloid malignancies.

Abstract:

:A longstanding endeavor to define the genetic lesions that drive myeloid malignances has stimulated a period of remarkable discovery. Enabled by technological advances that have sharply decreased the cost of DNA sequencing, the full compendium of common, recurrent somatic mutations in the coding genome of myeloid malignancies is nearly complete. As the focus of genetic discovery shifts to the noncoding genome, renewed attention is being applied to the clinical and biological implications of recent genomic advances. Although the potential for this newfound knowledge to influence the care of patients has not yet been realized, broad genetic surveys of patient samples are now being used to improve the accuracy of disease diagnosis, define a molecular taxonomy of myeloid malignancies, refine prognostic and predictive models, and identify novel therapeutic strategies. Here, we will review recent advances in the genetics of myeloid malignancies and discuss their potential impact on clinical practice.

journal_name

Blood

journal_title

Blood

authors

Lindsley RC,Ebert BL

doi

10.1182/blood-2013-06-460295

subject

Has Abstract

pub_date

2013-11-28 00:00:00

pages

3741-8

issue

23

eissn

0006-4971

issn

1528-0020

pii

blood-2013-06-460295

journal_volume

122

pub_type

杂志文章,评审

相关文献

BLOOD文献大全
  • Activation of the CD95 (APO-1/Fas) system in T cells from human immunodeficiency virus type-1-infected children.

    abstract::Increased apoptosis of CD4+ T cells is considered to be involved in CD4+ T-cell depletion in human immunodeficiency virus type-1 (HIV-1)-infected individuals progressing toward acquired immunodeficiency syndrome (AIDS). We have recently shown that CD95 (APO-1/Fas) expression is strongly increased in T cells of HIV-1-i...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Bäumler CB,Böhler T,Herr I,Benner A,Krammer PH,Debatin KM

    更新日期:1996-09-01 00:00:00

  • Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients.

    abstract::In an international collaborative study, a central histologic review identified 891 patients with essential thrombocythemia, strictly defined by World Health Organization criteria. After a median follow-up of 6.2 years, 109 (12%) patients experienced arterial (n = 79) or venous (n = 37) thrombosis. In multivariable an...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究

    doi:10.1182/blood-2011-02-339002

    authors: Carobbio A,Thiele J,Passamonti F,Rumi E,Ruggeri M,Rodeghiero F,Randi ML,Bertozzi I,Vannucchi AM,Antonioli E,Gisslinger H,Buxhofer-Ausch V,Finazzi G,Gangat N,Tefferi A,Barbui T

    更新日期:2011-06-02 00:00:00

  • A novel serpin expressed by blood-borne microfilariae of the parasitic nematode Brugia malayi inhibits human neutrophil serine proteinases.

    abstract::Serine proteinase inhibitors (serpins) play a vital regulatory role in a wide range of biological processes, and serpins from viruses have been implicated in pathogen evasion of the host defence system. For the first time, we report a functional serpin gene from nematodes that may function in this manner. This gene, n...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Zang X,Yazdanbakhsh M,Jiang H,Kanost MR,Maizels RM

    更新日期:1999-08-15 00:00:00

  • Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo.

    abstract::Defective function of dendritic cells (DC) in cancer has been recently described and may represent one of the mechanisms of tumor evasion from immune system control. We have previously shown in vitro that vascular endothelial growth factor (VEGF), produced by almost all tumors, is one of the tumor-derived factors resp...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Gabrilovich D,Ishida T,Oyama T,Ran S,Kravtsov V,Nadaf S,Carbone DP

    更新日期:1998-12-01 00:00:00

  • Hormonal effects on cell proliferation in a human erythroleukemia cell line (K562).

    abstract::We have investigated the hormonal responsiveness of K562 cells using a serum-substituted in vitro clonogenic assay. Dexamethasone inhibited colony formation by the K562 cells, and the inhibitory effect could be reversed by progesterone (10(-6) M). Fluoxymesterone caused a prominent enhancement of K562 colony growth, w...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Gauwerky C,Golde DW

    更新日期:1980-11-01 00:00:00

  • Specific iron chelators determine the route of ferritin degradation.

    abstract::Deferoxamine (DFO) is a high-affinity Fe (III) chelator produced by Streptomyces pilosus. DFO is used clinically to remove iron from patients with iron overload disorders. Orally administered DFO cannot be absorbed, and therefore it must be injected. Here we show that DFO induces ferritin degradation in lysosomes thro...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-05-224188

    authors: De Domenico I,Ward DM,Kaplan J

    更新日期:2009-11-12 00:00:00

  • In vitro regulation of granulopoiesis in human leukemia: application of an assay for colony-inhibiting cells.

    abstract::We describe two assays to detect the action of colony-inhibiting cells. In the first assay, we used a simple density separation technique to remove dense neutrophils (PMN) from suspensions of blood and of bone marrow cells prior to culture in semisolid agar. Conditions were arranged to ensure that control suspensions ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Broxmeyer HE,Baker FL,Galbraith PR

    更新日期:1976-03-01 00:00:00

  • B-cell antigen receptor signaling enhances chronic lymphocytic leukemia cell migration and survival: specific targeting with a novel spleen tyrosine kinase inhibitor, R406.

    abstract::Antigenic stimulation through the B-cell antigen receptor (BCR) is considered to promote the expansion of chronic lymphocytic leukemia (CLL) B cells. The spleen tyrosine kinase (Syk), a key component of BCR signaling, can be blocked by R406, a small-molecule Syk inhibitor, that displayed activity in CLL patients in a ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-03-212837

    authors: Quiroga MP,Balakrishnan K,Kurtova AV,Sivina M,Keating MJ,Wierda WG,Gandhi V,Burger JA

    更新日期:2009-07-30 00:00:00

  • Recombinant human interleukin-1 receptor antagonist in the treatment of steroid-resistant graft-versus-host disease.

    abstract::Acute graft-versus-host disease (GVHD) that is resistant to therapy is a highly lethal complication of marrow transplantation. Inflammatory cytokines such as interleukin-1 (IL-1) may be critical mediators of this process. If so, specific inhibition of IL-1 activity with recombinant human IL-1 receptor antagonist (IL-1...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Antin JH,Weinstein HJ,Guinan EC,McCarthy P,Bierer BE,Gilliland DG,Parsons SK,Ballen KK,Rimm IJ,Falzarano G

    更新日期:1994-08-15 00:00:00

  • Characterization of B-cell lines established from two X-linked severe combined immunodeficiency patients: interleukin-15 binds to the B cells but is not internalized efficiently.

    abstract::X-linked severe combined immunodeficiency (XSCID) is characterized by absent or profoundly reduced numbers of T cells and normal numbers of B cells in the circulation. Affected patients have mutations of the interleukin-2 (IL-2) receptor gamma chain gene. Using Epstein-Barr virus-transformed B-lymphoblastoid cell line...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Kumaki S,Ochs HD,Timour M,Schooley K,Ahdieh M,Hill H,Sugamura K,Anderson D,Zhu Q,Cosman D

    更新日期:1995-08-15 00:00:00

  • Erwinia asparaginase achieves therapeutic activity after pegaspargase allergy: a report from the Children's Oncology Group.

    abstract::AALL07P2 evaluated whether substitution of Erwinia asparaginase 25000 IU/m(2) for 6 doses given intramuscularly Monday/Wednesday/Friday (M/W/F) to children and young adults with acute lymphoblastic leukemia and clinical allergy to pegaspargase would provide a 48-hour nadir serum asparaginase activity (NSAA) ≥ 0.10 IU/...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2013-01-480822

    authors: Salzer WL,Asselin B,Supko JG,Devidas M,Kaiser NA,Plourde P,Winick NJ,Reaman GH,Raetz E,Carroll WL,Hunger SP

    更新日期:2013-07-25 00:00:00

  • Long-term follow-up of allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning for patients with chronic myeloid leukemia.

    abstract::Allogeneic hematopoietic stem-cell transplantation (HSCT) remains an effective strategy for inducing durable remission in chronic myeloid leukemia (CML). Reduced-intensity conditioning (RIC) regimens extend HSCT to older patients and those with comorbidities who would otherwise not be suitable candidates for HSCT. The...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-04-085969

    authors: Kebriaei P,Detry MA,Giralt S,Carrasco-Yalan A,Anagnostopoulos A,Couriel D,Khouri IF,Anderlini P,Hosing C,Alousi A,Champlin RE,de Lima M

    更新日期:2007-11-01 00:00:00

  • p52Shc is required for CXCR4-dependent signaling and chemotaxis in T cells.

    abstract::ShcA is an important mediator of Ras/MAPK activation in PTK-regulated pathways triggered by surface receptors. This function is subserved by the constitutively expressed p52-kDa isoform. Besides activating Ras, p52Shc couples the TCR to Rho GTPases, and thereby participates in actin cytoskeleton remodeling in T cells....

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-01-068411

    authors: Patrussi L,Ulivieri C,Lucherini OM,Paccani SR,Gamberucci A,Lanfrancone L,Pelicci PG,Baldari CT

    更新日期:2007-09-15 00:00:00

  • Inhibition of the intrinsic factor X activating complex by protein S: evidence for a specific binding of protein S to factor VIII.

    abstract::Protein S is a vitamin K-dependent nonenzymatic anticoagulant protein that acts as a cofactor to activated protein C. Recently it was shown that protein S inhibits the prothrombinase reaction independent of activated protein C. In this study, we show that protein S can also inhibit the intrinsic factor X activation vi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Koppelman SJ,Hackeng TM,Sixma JJ,Bouma BN

    更新日期:1995-08-01 00:00:00

  • Rituximab blocks binding of radiolabeled anti-CD20 antibodies (Ab) but not radiolabeled anti-CD45 Ab.

    abstract::Rituximab therapy is associated with a long in vivo persistence, yet little is known about the effect of circulating rituximab on B-cell non-Hodgkin lymphoma (B-NHL) targeting by the other available anti-CD20 monoclonal antibodies (MoAbs) (131)iodine-tositumomab and (90)yttrium-ibritumomab tiuxetan. Therefore we asses...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-01-132142

    authors: Gopal AK,Press OW,Wilbur SM,Maloney DG,Pagel JM

    更新日期:2008-08-01 00:00:00

  • Induction of fibrinogen binding and platelet aggregation as a potential intrinsic property of various glycoprotein IIb/IIIa (alphaIIbbeta3) inhibitors.

    abstract::The blockade of platelet integrin glycoprotein (GP) IIb/IIIa is a promising new antiplatelet strategy. The binding of ligands or of the ligand-mimetic peptide RGD causes a conformational change of GP IIb/IIIa from the nonactivated to the activated state. Because several blocking agents/inhibitors are ligand-mimetics, ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Peter K,Schwarz M,Ylänne J,Kohler B,Moser M,Nordt T,Salbach P,Kübler W,Bode C

    更新日期:1998-11-01 00:00:00

  • Gene therapy with adeno-associated virus vector 5-human factor IX in adults with hemophilia B.

    abstract::Gene therapy for hemophilia B aims to ameliorate bleeding risk and provide endogenous factor IX (FIX) activity/synthesis through a single treatment, eliminating the requirement for FIX concentrate. AMT-060 combines an adeno-associated virus-5 (AAV5) vector with a liver-specific promoter driving expression of a codon-o...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究

    doi:10.1182/blood-2017-09-804419

    authors: Miesbach W,Meijer K,Coppens M,Kampmann P,Klamroth R,Schutgens R,Tangelder M,Castaman G,Schwäble J,Bonig H,Seifried E,Cattaneo F,Meyer C,Leebeek FWG

    更新日期:2018-03-01 00:00:00

  • Metformin induces FOXO3-dependent fetal hemoglobin production in human primary erythroid cells.

    abstract::Induction of red blood cell (RBC) fetal hemoglobin (HbF; α2γ2) ameliorates the pathophysiology of sickle cell disease (SCD) by reducing the concentration of sickle hemoglobin (HbS; α2βS2) to inhibit its polymerization. Hydroxyurea (HU), the only US Food and Drug Administration (FDA)-approved drug for SCD, acts in part...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2017-11-814335

    authors: Zhang Y,Paikari A,Sumazin P,Ginter Summarell CC,Crosby JR,Boerwinkle E,Weiss MJ,Sheehan VA

    更新日期:2018-07-19 00:00:00

  • Pseudo-Bernard-Soulier syndrome: thrombocytopenia caused by autoantibody to platelet glycoprotein Ib.

    abstract::The Bernard-Soulier syndrome is an inherited bleeding disorder that is due to a deficiency in platelet glycoprotein Ib. Bernard-Soulier platelets fail to agglutinate in response to ristocetin despite normal levels of factor VIII:von Willebrand factor. We report a patient who developed severe refractory thrombocytopeni...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Devine DV,Currie MS,Rosse WF,Greenberg CS

    更新日期:1987-08-01 00:00:00

  • Acute myeloid leukemia with mutated nucleophosmin (NPM1): is it a distinct entity?

    abstract::After the discovery of NPM1-mutated acute myeloid leukemia (AML) in 2005 and its subsequent inclusion as a provisional entity in the 2008 World Health Organization classification of myeloid neoplasms, several controversial issues remained to be clarified. It was unclear whether the NPM1 mutation was a primary genetic ...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2010-08-299990

    authors: Falini B,Martelli MP,Bolli N,Sportoletti P,Liso A,Tiacci E,Haferlach T

    更新日期:2011-01-27 00:00:00

  • Distinct hematopoietic progenitor compartments are delineated by the expression of aldehyde dehydrogenase and CD34.

    abstract::A broad range of hematopoietic stem cells and progenitors reside within a fraction of umbilical cord blood (UCB) that exhibits low light scatter properties (SSC(lo)) and high expression of aldehyde dehydrogenase (ALDH(br)). Many SSC(lo) ALDH(br) cells coexpress CD34; however, other cells express either ALDH or CD34. T...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-09-3652

    authors: Storms RW,Green PD,Safford KM,Niedzwiecki D,Cogle CR,Colvin OM,Chao NJ,Rice HE,Smith CA

    更新日期:2005-07-01 00:00:00

  • Large granular lymphocytes in human peripheral blood: ultrastructural and cytochemical characterization of the granules.

    abstract::Large granular lymphocytes (LGL) are defined as nonadherent mononuclear cells with cytoplasmic azurophilic granules, avid receptors for the Fc portion of IgG, and cytotoxic functions (NK or ADCC activities). In the present study, the granules of LGL isolated from human peripheral blood have been analyzed by enzyme cyt...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Grossi CE,Cadoni A,Zicca A,Leprini A,Ferrarini M

    更新日期:1982-02-01 00:00:00

  • Factor VIII brand and the incidence of factor VIII inhibitors in previously untreated UK children with severe hemophilia A, 2000-2011.

    abstract::The effect of recombinant factor VIII (rFVIII) brand on inhibitor development was investigated in all 407 severe hemophilia A previously untreated patients born in the United Kingdom (UK) between 1 January 2000 and 31 December 2011. Eighty-eight (22%) had been in the RODIN study. Information was extracted from the Nat...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-07-580498

    authors: Collins PW,Palmer BP,Chalmers EA,Hart DP,Liesner R,Rangarajan S,Talks K,Williams M,Hay CR,UK Haemophilia Centre Doctors’ Organization.

    更新日期:2014-11-27 00:00:00

  • Function of wild-type or mutant Rac2 and Rap1a GTPases in differentiated HL60 cell NADPH oxidase activation.

    abstract::Studies of neutrophil nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activation in a cell-free system showed that the low molecular-weight guanosine triphosphatase (GTPase) Rac was required, and that Rap1a may participate in activation of the catalytic complex. Full-length posttranslationally modified Rac...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Gabig TG,Crean CD,Mantel PL,Rosli R

    更新日期:1995-02-01 00:00:00

  • Half-lives of beta and gamma globin messenger RNAs and of protein synthetic capacity in cultured human reticulocytes.

    abstract::The turnover rates of beta and gamma globin messenger RNAs and of beta and gamma globin protein synthesis in human reticulocytes have been measured. Our goal was to determine whether beta globin mRNA is significantly more stable than gamma globin mRNA during the final stages of erythroid cell maturation. Such a result...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Ross J,Sullivan TD

    更新日期:1985-11-01 00:00:00

  • Sodium salicylate activates caspases and induces apoptosis of myeloid leukemia cell lines.

    abstract::Nonsteroidal antiinflammatory agents (NSAIA) have been shown to exert potent chemopreventive activity against colon, lung, and breast cancers. In this study, we show that at pharmacological concentrations (1 to 3 mmol/L) sodium salicylate (Na-Sal) can potently induce programmed cell death in several human myeloid leuk...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Klampfer L,Cammenga J,Wisniewski HG,Nimer SD

    更新日期:1999-04-01 00:00:00

  • Hyperantithrombotic, noncytoprotective Glu149Ala-activated protein C mutant.

    abstract::Activated protein C (APC) reduces mortality in severe sepsis patients. APC exerts anticoagulant activities via inactivation of factors Va and VIIIa and cytoprotective activities via endothelial protein C receptor and protease-activated receptor-1. APC mutants with selectively altered and opposite activity profiles, th...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-10-183327

    authors: Mosnier LO,Zampolli A,Kerschen EJ,Schuepbach RA,Banerjee Y,Fernández JA,Yang XV,Riewald M,Weiler H,Ruggeri ZM,Griffin JH

    更新日期:2009-06-04 00:00:00

  • Biomarkers for prediction of venous thromboembolism in cancer.

    abstract::Cancer patients are at increased risk of deep vein thrombosis and pulmonary embolism. The incidence among different groups of cancer patients varies considerably depending on clinical factors, the most important being tumor entity and stage. Biomarkers have been specifically investigated for their capacity of predicti...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2013-04-460147

    authors: Pabinger I,Thaler J,Ay C

    更新日期:2013-09-19 00:00:00

  • Antibody-induced modulation and intracellular transport of CD10 and CD19 antigens in human B-cell lines: an immunofluorescence and immunoelectron microscopy study.

    abstract::Antibody-induced antigenic modulation (AIAM) of CD10 and CD19 was studied on NALM-6, RAJI, and JOK-1 cell lines using fluorescence microscopy (FM), flow cytometry (FCM), and immunoelectron microscopy (IEM). Cross-linking with monoclonal antibodies (MoAbs) induced rapid redistribution of CD10 and CD19 on the cell surfa...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Pulczynski S,Boesen AM,Jensen OM

    更新日期:1993-03-15 00:00:00

  • Short remission durations in therapy-related leukemia despite cytogenetic complete responses to high-dose cytarabine.

    abstract::Seventeen patients with therapy-related myelodysplastic syndrome (t-MDS) or therapy-related acute nonlymphocytic leukemia (t-ANLL) were treated with single-agent high-dose cytarabine (HDAC; 1 to 3 g/m2 every 12 hours for 12 doses). The initial neoplasm was still present in eight patients when t-MDS/t-ANLL developed. F...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Larson RA,Wernli M,Le Beau MM,Daly KM,Pape LH,Rowley JD,Vardiman JW

    更新日期:1988-10-01 00:00:00